Streetbeat News

Price Targets

CPAY

Jefferies analyst Trevor Williams maintains a Buy rating on Corpay (NYSE:CPAY) and raises the price target from $350 to $375.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 7:20 pm

CUBE

Jefferies analyst Jonathan Petersen maintains a Buy rating on CubeSmart and raises the price target from $53 to $62.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 7:10 pm

ROKU

SHOP

TTD

Roku Inc. is focusing on accelerating platform revenue growth, highlighted by its new Roku Ads Manager with Shopify integration. Analysts have raised price targets, citing Roku's strategic position in the streaming ecosystem and potential ad revenue growth through partnerships.

Portfolio Pulse from Surbhi Jain

September 18, 2024 | 7:05 pm

NSA

Jefferies analyst Jonathan Petersen has maintained a Buy rating on National Storage (NYSE:NSA) and raised the price target from $47 to $54.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 7:05 pm

PSA

Jefferies analyst Jonathan Petersen maintains a Buy rating on Public Storage (NYSE:PSA) and raises the price target from $360 to $422.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 7:03 pm

ZVRA

Canaccord Genuity has maintained its Buy rating on Zevra Therapeutics but lowered the price target from $24 to $22.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 6:57 pm

CRVO

Chardan Capital has initiated coverage on CervoMed (NASDAQ:CRVO) with a Buy rating and set a price target of $55.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 6:38 pm

ARTY

IDGT

SMCI

Needham analyst Quinn Bolton initiated coverage on Super Micro Computer Inc (SMCI) with a Buy rating and a $600 price target, citing margin recovery and AI infrastructure growth. The stock reflects internal control risks, and Super Micro is expanding manufacturing capacity. Investors can also gain exposure through ETFs ARTY and IDGT.

Portfolio Pulse from Anusuya Lahiri

September 18, 2024 | 6:37 pm

LKQ

Barrington Research analyst Gary Prestopino has reiterated an 'Outperform' rating for LKQ Corporation, maintaining a price target of $60.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 6:30 pm

IMUX

EF Hutton analyst Jason Kolbert has reiterated a Buy rating for Immunic (NASDAQ:IMUX) and maintained a price target of $17.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 6:24 pm